An inherited susceptibility or predisposition to developing type 1 diabetes mellitus that has material basis in mutation of the locus at chromosome 2q31.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning type 1 diabetes mellitus 7
Updated Nov 20, 2025
EMA recommends granting marketing authorization for Teizeild (teplizumab) to delay the onset of stage 3 type 1 diabetes in adults. This first-in-class treatment represents a significant advancement in diabetes management.